Table 1. Clinical characteristics of the patients by study groups.
| NAC (n = 20) |
Non-NAC (n = 20) |
Total (n = 40) |
P | |
|---|---|---|---|---|
| Age (years) | 53 (48–59) | 46 (43–53) | 50 (44–55) | 0.096 |
| Body mass index | 24.3 (21.8–26.9) | 22.8 (21.3–24.8) | 23.7 (21.4–25.5) | 0.209 |
| Serum glucose (mg/dL) | 105 (100–113) | 105 (100–114) | 105 (100–113) | 0.756 |
| Intubated time (minutes) | 175 (160–225) | 182 (153–213) | 177 (160–217) | 0.850 |
| Duration of chemotherapy (days) | 108 (105–120) | N/A | ||
| Days from last chemotherapy | 22 (20–27) | N/A | ||
| Pre-chemotherapy clinical stage | <0.001*** | |||
| cI | 0 | 12 | ||
| cII | 9 | 8 | ||
| cIII | 11 | 0 |
Notes:
Abbreviations: NAC, Neoadjuvant chemotherapy; N/A, not applicable.
***P < 0.001 are considered as statistically significant.
Continuous variables are reported as median (interquartile range).